论文部分内容阅读
目的研究三联法治疗难治性宫缩乏力性产后出血的临床疗效。方法选取我院2012年6月至2015年12月收治的难治性宫缩乏力性产后出血产妇60例为研究对象,将其随机分为观察与对照组,各30例。对照组产妇采用缩宫素与宫腔纱布填塞进行治疗,观察组产妇在缩宫素治疗的基础上采用产妇采用三联法(欣母沛、垂体后叶素、催产素)进行治疗,对比分析两组产妇的临床治疗效果。结果治疗后,观察组产妇的临床治疗有效率为86.67%,高于对照组的66.67%(P<0.05);24 h出血量≤200 m L产妇中,观察组占比为66.67%,显著高于对照组的33.33%;观察组200 m L<出血量<300 m L的产妇占20.00%,显著低于对照组的53.33%(P<0.05);观察组的并发症发生率为6.67%,显著低于对照组的20.00%(P<0.05)。结论三联法治疗难治性宫缩乏力性产后出血,临床疗效显著,能有效缓解产妇各种症状,值得临床推广。
Objective To study the clinical efficacy of triple therapy in the treatment of refractory uterine inertia postpartum hemorrhage. Methods Sixty female patients with refractory uterine inertia postpartum hemorrhage admitted from June 2012 to December 2015 in our hospital were selected as the research objects, which were randomly divided into observation and control group, 30 cases in each group. The control group maternal use of oxytocin and uterine gauze packing for treatment, observation group maternal oxytocin treatment based on the use of triple therapy (Xin-Pei, pituitrin, oxytocin) for treatment, comparative analysis of two Group maternal clinical effect. Results After treatment, the effective rate of clinical treatment in the observation group was 86.67%, which was 66.67% higher than that in the control group (P <0.05). Among the 24-hour bleeding ≤200 m L, the proportion of the observation group was 66.67% (33.33%) in the control group; 20.00% in the observation group 200 m L <20.00% of the bleeding volume was significantly lower than that in the control group (P <0.05); the complication rate in the observation group was 6.67% Significantly lower than 20.00% of the control group (P <0.05). Conclusion triple therapy for refractory uterine inertia postpartum hemorrhage, clinical efficacy was significant, can effectively alleviate the various symptoms of maternal, worthy of clinical promotion.